Board Meeting

Intimation about Board Meeting scheduled to be held on Saturday, September 21, 2019 to consider the report of valuation of the wholly owned subsidiary company, Nueclear Healthcare Limited (NHL), obtained from a second valuer engaged for the purpose, in the context of deciding whether to retain the Company’s shareholding in NHL or dispose it of.